Healthcare Finance News August 10, 2021
Precision medicine is biased toward educated, socioeconomic groups, says Abbvie’s Chris Boone, speaking at HIMSS21.
Diversity in clinical trials is lacking, according to Chris Boone, vice president, Global Head of Health Economics and Outcomes Research at Abbvie, a pharmaceutical and research development company.
Less than 16% people of color are in clinical trials, when 39% of the U.S. population is made up of people of color. An estimated 1% of Hispanic Americans are represented in clinical trials, and they are 16% of the population.
Moderna took heat for failing to recruit diverse volunteers for its COVID-19 vaccine, according to Boone, who spoke Tuesday at HIMSS21 for the session, “Big Data Matters in Big Pharma: A Look at Regulations, Ethics, and...
Today's Sponsors
Today's Sponsor